Mogrify enters research collaboration with the MRC Laboratory of Molecular Biology
Drug Discovery Today
JANUARY 12, 2021
Exploratory research project aims to develop novel protein expression systems via cell reprogramming
Drug Discovery Today
JANUARY 12, 2021
Exploratory research project aims to develop novel protein expression systems via cell reprogramming
Drug Target Review
FEBRUARY 19, 2024
I always found science fascinating, but I really fell in love with it in high school when I was introduced to biochemistry and molecular biology. Biochemistry and molecular biology fascinated me in school. I did my PhD project on elucidating the role of the p53 protein that is relevant in many cancers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
NOVEMBER 9, 2023
The luncheon presentation will be given by Hans Gerstmans, Postdoctoral Researcher, Laboratory for Biomolecular Discovery & Engineering, KU Leuven, VIB, alongside Wai Long Tam, Head of Technology Watch at VIB, Technology Watch, VIB.
The Pharma Data
JANUARY 13, 2021
based Mogrify Limited expanded its research collaboration with MRC Laboratory of Molecular Biology. UV1 is a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. Mogrify – U.K.-based
Let's personalize your content